Clinical Dermatology Research JournalISSN: 2576-1439

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Review Article, Clin Dermatol Res J Vol: 6 Issue: 5

Anti-Androgen Therapy for the Treatment of Female Adult Acne

Donald Brown*

Department of Dermatology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany

*Corresponding Author: Donald Brown
Department of Dermatology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany

Received: July 30, 2021; Accepted: August 13, 2021; Published: August 20, 2021

Citation: Brown D, 2021, Anti-Androgen Therapy for the Treatment of Female Adult Acne. Clin Dermatol Res J 6:5. (165)

Keywords: Anti-Androgen, Skin Inflammation, Acne


Acne vulgaris is a multifactorial disease of the pilosebaceous unit as a result of androgen-induced increased sebum production, altered keratinisation, inflammation, and hair follicle bacterial colonisation by Propionibacterium acnes. The clinical elements of skin break out incorporate seborrhea, comedones, and papules and pustules. Knobs and pimples are seen in extreme nodulocystic skin break out and scarring can follow. Skin inflammation can happen alone or with indications of hyperandrogenism like hirsutism, alopecia and feminine anomaly.

Skin inflammation vulgaris is a typical motivation behind why grown-up ladies present to dermatologists and can be a clinical test to treat. In spite of the fact that skin break out is most ordinarily connected with puberty, it frequently perseveres into adulthood. Perkins et al considers commonness of skin break out in 2895 ladies and found in excess of a quarter had skin break out and in spite of the fact that skin break out crested in adolescents it keeps on being predominant through the fifth decade [1,2]. Grown-up skin inflammation identifying with flowing androgens is regularly alluded to as late-beginning or post-young adult skin inflammation. Skin inflammation can cause huge mental pain, which has been displayed to improve with viable treatment. Against androgen treatment is shown for moderate to extreme papulopustular/nodular skin inflammation in female patients impervious to initially line treatment or where hyperandrogenism is recognized. Albeit standard skin inflammation treatments can be effectively used to treat skin break out in grown-up female patients, against androgen treatment is a viable restorative choice that might give a chance to more readily target skin break out in this populace, in any event, when other foundational treatments have been ineffective. This audit talks about non-prophylactic hormonal treatment including cyproterone acetic acid derivation, spironolactone and flutamide. Contraceptives with androgenic exercises and skin medicines are past the extent of this audit [3].

Androgens assume a significant part in the pathophysiology and treatment of skin inflammation. Other significant variables are incendiary arbiters delivered into the skin, change of the keratinisation interaction prompting comedowns, and follicular colonization by P acnes. There is no skin break out without sebum, which fills in as a supplement hotspot for P acnes, and androgens are the major sebo jungle chemicals.

Differential Diagnosis of Acne in Women

An exhaustive clinical history and actual assessment is necessary for female adults presenting with acne. The normal differential finding of grown-up female skin inflammation incorporates: rosacea, seborrheic dermatitis, and hyperandrogenism. Signs and manifestations of hyperandrogenism incorporate hirsutism, alopecia, amenorrhea or oligomenorrhea, and virilization, as confirmed by extending of the voice, clitoromegaly and expanded bulk. Hirsutism is the most widely recognized sign (70-80%) and is profoundly connected with raised degrees of free testosterone [4].

The most well-known reason for hyperandrogenism is PCOS. The Rotterdam agreement models characterize conclusion of PCOS as two of the accompanying three rules: amenorrhea or oligomenorrhea, biochemical or clinical hyperandrogenism, and ultrasonographic documentation of expanded follicle check (> 12) or follicular volume (> 10 cm) per ovary. Dermatologists ought to be comfortable with the demonstrative work-up of PCOS, which comprises of evaluation of endocrine (aggregate and free testosterone, FSH, LH, prolactin, 17-hydroxyprogesterone and DHEA) and metabolic boundaries.

A significant differential to know about is androgen-discharging tumors which can happen in all ages and present with quick beginning skin break out. Undeniable degrees of testosterone (> 150-200 ngdL1) related with ordinary degrees of DHEA are intriguing for ovarian tumor. Undeniable degrees of DHEA (> 8000 ng mL-1) are intriguing for adrenal tumors. Somewhat raised degrees of DHEA (4000-8000 ng mL-1) are found in CAH, PCOS and Cushing illness. Significant degrees of 17-OHP and a positive adrenocorticotropic chemical (ACTH) incitement test are vital for make the conclusion of CAH [5].


  1. Law MP, Chuh AA, Lee A, Molinari N (2010) Acne prevalence and beyond: acne disability and its predictive factors among Chinese late adolescents in Hong Kong. Clin Exp Dermatol 35: 16-21.
  2. Collier CN, Harper JC, Cafardi JA, Cantrell WC, Wang W, et al. (2008) The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 58: 56-59.
  3. Perkins AC, Maglione J, Hillebrand GG, Miyamoto K, Kimball AB (2012) Acne vulgaris in women: prevalence across the life span. J Womens Health (Larchmt) 21: 223-230.
  4. Seirafi H, Farnaghi F, Vasheghani-Farahani A, Alirezaie NS, Esfahanian F, et al. (2007) Assessment of androgens in women with adult-onset acne. Int J Dermatol 46: 1188-1191.
  5. Pagliarello C, Di Pietro C, Tabolli S (2015) A comprehensive health impact assessment and determinants of quality of life, health and psychological status in acne patients. G Ital Dermatol Venereol 150: 303-308.
international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination

Media Partners